Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts
Clinical trial NCT03160079 · COMPLETED
Trial details
- NCT number
- NCT03160079
- Sponsor
- University of California, San Diego
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-04
- Primary completion
- 2021-12-21
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.